The expression of RRM2 in iCCA patients was evaluated with immunohistochemistry (IHC) in iCCA cohort 4, which included 31 paired FFPE iCCA tumors and adjacent non-tumor FFPE liver tissues (Table 1). Here, RRM2 is linked to neoplasm.